NO970142L - Heterocyklus-kondenserte morfin-derivater - Google Patents

Heterocyklus-kondenserte morfin-derivater

Info

Publication number
NO970142L
NO970142L NO970142A NO970142A NO970142L NO 970142 L NO970142 L NO 970142L NO 970142 A NO970142 A NO 970142A NO 970142 A NO970142 A NO 970142A NO 970142 L NO970142 L NO 970142L
Authority
NO
Norway
Prior art keywords
pct
heterocycle
condensed
morphine derivatives
sec
Prior art date
Application number
NO970142A
Other languages
English (en)
Other versions
NO970142D0 (no
NO315119B1 (no
Inventor
Giulio Dondio
Silvano Ronzoni
Original Assignee
Smithkline Beecham Farma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Farma filed Critical Smithkline Beecham Farma
Publication of NO970142D0 publication Critical patent/NO970142D0/no
Publication of NO970142L publication Critical patent/NO970142L/no
Publication of NO315119B1 publication Critical patent/NO315119B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Transplantation (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19970142A 1994-07-14 1997-01-13 Heterocyklus-kondenserte morfin-derivater, anvendelse derav og farmasöytiske blandinger inneholdende dem NO315119B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI941463A IT1270612B (it) 1994-07-14 1994-07-14 Derivati eterociclo-condensatori di morfinoidi
PCT/EP1995/002694 WO1996002545A1 (en) 1994-07-14 1995-07-07 Heterocycle-condensed morphinoid derivatives

Publications (3)

Publication Number Publication Date
NO970142D0 NO970142D0 (no) 1997-01-13
NO970142L true NO970142L (no) 1997-03-12
NO315119B1 NO315119B1 (no) 2003-07-14

Family

ID=11369271

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19970142A NO315119B1 (no) 1994-07-14 1997-01-13 Heterocyklus-kondenserte morfin-derivater, anvendelse derav og farmasöytiske blandinger inneholdende dem

Country Status (19)

Country Link
US (1) US5981540A (no)
EP (1) EP0770081B1 (no)
JP (1) JP3480936B2 (no)
CN (1) CN1051086C (no)
AT (1) ATE236169T1 (no)
AU (1) AU686413B2 (no)
BR (1) BR9508406A (no)
CA (1) CA2194877A1 (no)
CZ (1) CZ9897A3 (no)
DE (1) DE69530205T2 (no)
ES (1) ES2196069T3 (no)
HU (1) HUT76812A (no)
IT (1) IT1270612B (no)
MX (1) MX9700373A (no)
NO (1) NO315119B1 (no)
NZ (1) NZ289858A (no)
PL (1) PL182747B1 (no)
WO (1) WO1996002545A1 (no)
ZA (1) ZA955782B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985880A (en) * 1996-06-05 1999-11-16 Delta Pharmaceuticals Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds
KR19990077125A (ko) * 1996-01-10 1999-10-25 파올로 비지, 엔리꼬 카쭐라니 헤테로고리-축합 모르핀 유도체 (ⅱ)
US6103722A (en) * 1997-07-23 2000-08-15 The Medical College Of Wisconsin Research Foundation Inc. Ischemic preconditioning
IT1312083B1 (it) * 1999-04-20 2002-04-04 Smithkline Beecham Spa Derivati morfinoidi, procedimento per la loro preparazione e loroimpiego terapeutico.
CA2380810C (en) 1999-08-13 2006-03-14 Southern Research Institute Pyridomorphinans and use thereof
EP1210084A4 (en) * 1999-08-13 2002-11-13 Southern Res Inst PYRIDOMORPHINANS, THIENOMORPHINANS AND THEIR USE
US7015326B1 (en) * 1999-08-13 2006-03-21 Southern Research Institute Pyridomorphinans, thienomorphinans and use thereof
GB0025056D0 (en) * 2000-10-12 2000-11-29 Smithkline Beecham Spa Novel compounds
JP2007504150A (ja) * 2003-08-27 2007-03-01 サザン・リサーチ・インスティテュート ピリドモルヒナン（ｐｙｒｉｄｏｍｏｒｐｈｉｎａｎ）類及びピリダジノモルヒナン（ｐｙｒｉｄａｚｉｎｏｍｏｒｐｈｉｎａｎ）類、並びに、それらの使用
WO2013166271A1 (en) * 2012-05-02 2013-11-07 Southern Research Institute Heterocycle-fused morphinans, use thereof and preparation thereof
US9624223B2 (en) 2013-03-08 2017-04-18 The Kitasato Institute Morphinan derivative
MA40170A (fr) * 2014-06-13 2017-04-19 Purdue Pharma Lp Dérivés hétérocycliques de morphinan et leur utilisation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816586A (en) 1987-07-29 1989-03-28 Regents Of The University Of Minnesota Delta opioid receptor antagonists
US5223507A (en) * 1992-01-21 1993-06-29 G. D. Searle & Co. Method of using opioid compounds as delta opioid selective agonist analgesics
US5225417A (en) * 1992-01-21 1993-07-06 G. D. Searle & Co. Opioid agonist compounds

Also Published As

Publication number Publication date
CZ9897A3 (en) 1997-07-16
ITMI941463A0 (it) 1994-07-14
AU2982495A (en) 1996-02-16
ZA955782B (en) 1996-02-26
JP3480936B2 (ja) 2003-12-22
JPH10502657A (ja) 1998-03-10
HUT76812A (en) 1997-11-28
EP0770081A1 (en) 1997-05-02
ATE236169T1 (de) 2003-04-15
CA2194877A1 (en) 1996-02-01
US5981540A (en) 1999-11-09
NO970142D0 (no) 1997-01-13
ITMI941463A1 (it) 1996-01-14
CN1161041A (zh) 1997-10-01
CN1051086C (zh) 2000-04-05
IT1270612B (it) 1997-05-07
PL318148A1 (en) 1997-05-12
DE69530205T2 (de) 2004-02-05
PL182747B1 (pl) 2002-02-28
NZ289858A (en) 1998-01-26
DE69530205D1 (de) 2003-05-08
EP0770081B1 (en) 2003-04-02
ES2196069T3 (es) 2003-12-16
HU9700073D0 (en) 1997-02-28
MX9700373A (es) 1998-03-31
WO1996002545A1 (en) 1996-02-01
BR9508406A (pt) 1997-12-23
NO315119B1 (no) 2003-07-14
AU686413B2 (en) 1998-02-05

Similar Documents

Publication Publication Date Title
TR199801348T2 (xx) Heterosikl-kondanse morfinoid t�revleri(II).
MX9605903A (es) Derivados de quinolina como antagonistas del receptor nk3 de taquicinina.
DK0760661T3 (da) Farmaceutiske sammensætninger omfattende en opiat-antagonist og calciumsalte, deres anvendelse til behandling af endorfin-m
NO970142D0 (no) Heterocyklus-kondenserte morfin-derivater
TR200000374T2 (tr) Akut akciğer harabiyeti ve fibrozitinin alfavbeta6 antagonistleriyle tedavisi.
DK0804196T3 (da) Anvendelse af serotoninantagonister (5HT 3) til behandling af fibromyalgia
ATE224386T1 (de) Neue in 6-position substituierte phenanthridine
EP1133291A4 (en) THROMCOCYTOPENIA TREATMENTS
YU48698A (sh) Karboksamidni derivati pirolidina, piperidina i heksahidroazepina za lečenje oboljenja na bazi tromboze
NO982778L (no) Morfinderivater med smertestillende virkning
NZ329807A (en) NK-1 receptor antagonists and P receptor antagonists 2-Diarylmethyl-3-amino-1-azabicyclo[2.2.2]octane derivatives and amino substituted N-containing rings as agents for treating irritable bowel syndrome
NZ300942A (en) 1-aryl-2-acylamino-ethane derivatives as neurokinin 1 antagonists
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
DE59510713D1 (de) N-substituierte 3-azabicyclo(3.2.0)heptan-derivate als neuroleptika
TR199801665T2 (xx) Makular �demin engellenmesi i�in karbonik anhidraz inhibit�rlerinin kullan�m�.
NZ335052A (en) Piperazino derivatives as neurokinin antagonists
MX9603199A (es) Antagonistas de receptores a endotelina.
ATE294802T1 (de) 3-alkylimidazopyridine
SE9404438D0 (sv) New process
AR021502A1 (es) Uso de derivados de azabicicloalcanos n-sustituidos para el tratamiento de enfermedades del sistema central nervioso
ZA962946B (en) Anellated beta-carbolines
JO1553B1 (en) New units N- (3- Hydroxy-4-Piperidinyl) benzamide
MX9802024A (es) Derivados de diarilalquenilamina.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees